NLR predicted long-term clinical outcomes of stable CAD patients who underwent elective percutaneous coronary intervention (PCI) and had peri-procedural low high-sensitivity C-reactive protein (hs-CRP) levels (<2.0 mg/L) [75]. Here, CRP is linked to coronary artery disorder.